NCT07524205Recruiting
Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
Source: ClinicalTrials.gov · Last updated 4 Jun 2026
Brief summary (registry, in English)
The overarching goal of this explanatory mixed methods study is to evaluate how older people living with type 2 diabetes (T2D) integrate continuous glucose monitor (CGM) and activity data in diabetes self-management, and how this technology supports reduced sedentary behavior (SB) and improved glucose control.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 3 Apr 2026
- Start date
- May 2026
- Primary completion date
- Oct 2027
- Lead sponsor
- University of Minnesota
- Diseases
- Type 2 diabetes
- NCT number
- NCT07524205
What you commit to
- Study type: Interventional
- Planned participants: 60
- From May 2026 to the primary completion date, Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 1 diabetes
- Dementia
- Any of the following conditions that may impact SB:
- Severe pulmonary disease
- Severe osteoarthritis
- Class III/IV heart failure
- Require wheelchair or walker
Other
- Use of a CGM for ≥1 month in past 1 year
- Not willing to use/wear the CGM, activPAL, or Fitbit
Who the study is looking for
- Aged 55 years and older
- Self-reported T2D for ≥5 years
- Speak and read English
Age in the registry: 55 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.